• June 3-6, 2024
  • San Diego Convention Center, California


Carolyn Ng

Carolyn Ng, PhD

Partner and Managing Director
TPG Life Sciences Innovations
Dr. Ng is a Partner and Managing Director at TPG Life Sciences Innovations based in San Francisco, where she leads investments into transformative companies of early to mid-stage in different therapeutic areas. She currently serves on the board of directors of Mbrace Therapeutics and Bicara Therapeutics. Prior to joining TPG in 2021, Dr. Ng was a Managing Director at Vertex Ventures HC, a global healthcare and life sciences venture fund, where she co-headed the investment team. Dr. Ng has previously served on the board of directors for other promising public and private life sciences companies including Bicycle Therapeutics PLC (NASDAQ: BCYC), Boundless Bio, Obsidian Therapeutics, 28-7 Therapeutics, Epirium Bio, Nuvaira, and a board observer to Visterra (acquired by Otsuka Pharmaceutical). Carolyn is a mentor to the Women in Bio Boardroom Ready Program. She also currently serves on the panel of the Singapore Therapeutics Development Review Panel, a funding scheme aimed at identifying high-value drug discovery and development projects from the public research community in Singapore. In 2020, she was named 20 under 40 Next Generation of Biopharma Leaders by Endpoints News, a well-established life sciences news organization. Dr. Ng holds a PhD in Cancer Molecular Biology from the National University of Singapore, where she was the recipient of the prestigious NGS, Integrative Sciences and Technology, PhD scholarship.
Speaking In

white squarewhite


Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.